Explore the potential of AI with industry experts.

What role will CAR-Tregs play in the growing advanced therapy landscape?

Though in theory, biosimilars should help improve medicines access, what challenges still stand in the way of therapeutic equality and equity?

Celebrate the people, companies, and innovations had the biggest impact on pharma in the last year.

What do companies need to consider when developing next-gen medicines for rare diseases?

We sat down to talk shop with Novo Nordisk Executive Vice President Ludovic Helfgott

Overcoming supply chain woes will require digital intervention.

Medicines Patent Pool has joined forces with over 30 generic manufacturers to help ensure access to anti-COVID-19 medicines for all.

That which we call rosaimab by any other name would find regulatory approval and commercial success. Or would it?

An industry consortium is tackling one of pharma’s biggest drug-related challenges.